The GLP-1 drugs, including Mounjaro and Wegovy, work by mimicking the action of hormones that make you feel full, while ...

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

Refusing the subscription would be a good test of the friendship. If it continues, your friend is friends with you for who ...

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...

A knock-on effect from the use Ozempic is a change of diet, including a reliance on caffeine and low carbs. However, this ...

These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.

There are a few potential risks to keep in mind with rice water, including some food safety concerns.

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

A handful of New York City restaurants have been putting smaller portion sizes on their menus amid the rise of weight-loss ...

In his new book, a former FDA commissioner unpacks the latest science on metabolism, weight loss, and how GLP-1 drugs ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Indian drugmaker Biocon has abandoned plans to market generic versions of Novo Nordisk’s hot-selling diabetes and weight-loss drugs in China due to local competition, a senior executive said.